Aminoquinoline derivatives and their use as adenosine A3 ligands

3 The present invention relates to an adenosine Areceptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use o...

Full description

Saved in:
Bibliographic Details
Main Authors Aranyi, Peter, Batori, Sandor, Timari, Geza, Boer, Kinga, Kapui, Zoltan, Mikus, Endre, Urban-Szabo, Katalin, Gerber, Katalin, Vargane Szeredi, Judit, Finet, Michel
Format Patent
LanguageEnglish
Published 21.09.2010
Online AccessGet full text

Cover

More Information
Summary:3 The present invention relates to an adenosine Areceptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use of the ligand, to its preparation, and intermediates of the ligand of the general formula (II″), (III″), (IV″), (V″), (VI″), (VII″), (VIII″) and (XIII″) and their preparation.